Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41

被引:16
作者
Ashkenazi, Avraham [1 ]
Viard, Mathias [2 ,3 ]
Wexler-Cohen, Yael [1 ]
Blumenthal, Robert [2 ]
Shai, Yechiel [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[2] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA
[3] Natl Canc Inst Frederick, SAIC Frederick Inc, Basic Res Program, Frederick, MD 21701 USA
基金
美国国家卫生研究院; 以色列科学基金会;
关键词
HIV-1 fusion inhibitor; peptide-membrane interaction; IMMUNODEFICIENCY-VIRUS TYPE-1; DISULFIDE-ISOMERASE; INFLUENZA HEMAGGLUTININ; ATOMIC-STRUCTURE; 6-HELIX BUNDLE; CORE STRUCTURE; CELL FUSION; ENTRY; RECEPTOR; GLYCOPROTEIN;
D O I
10.1096/fj.10-175752
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fusion of human immunodeficiency virus (HIV-1) with target cells is mediated by the gp41 transmembrane envelope protein. The loop region within gp41 contains 2 crucial cysteines that play an unknown role in HIV-cell fusion. On the basis of cell-cell fusion assay, using human T-cell lines [Jurkat E6-1 and Jurkat HXBc2(4)], and virus-cell fusion assay, using fully infectious HIV-1 HXBc2 virus and TZM-bl human cell line, we provide evidence that the oxidation state of the disulfide bond within a loop domain peptide determines its activity. The oxidized (closed) form inhibits fusion, while the reduced (opened) form enhances hemifusion. These opposite activities reach 60% difference in viral fusion. Both forms of the loop domain interact with gp41: the opened form enhances gp41 folding into a bundle, whereas the closed form inhibits this folding. Therefore, the transformation of the cysteines from a reduced to an oxidized state enables the loop to convert from opened to closed conformations, which assists gp41 to fold and induces hemifusion. The significant conservation of the loop region within many envelope proteins suggests a general mechanism, which is exploited by viruses to enhance entry into their host cells.-Ashkenazi, A., Viard, M., Wexler-Cohen, Y., Blumenthal, R., Shai, Y. Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41. FASEB J. 25, 2156-2166 (2011). www.fasebj.org
引用
收藏
页码:2156 / 2166
页数:11
相关论文
共 70 条
[31]   Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: Implications for the viral fusion mechanism [J].
Judice, JK ;
Tom, JYK ;
Huang, W ;
Wrin, T ;
Vennari, J ;
Petropoulos, CJ ;
McDowell, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13426-13430
[32]   LIPID-ANCHORED INFLUENZA HEMAGGLUTININ PROMOTES HEMIFUSION, NOT COMPLETE FUSION [J].
KEMBLE, GW ;
DANIELI, T ;
WHITE, JM .
CELL, 1994, 76 (02) :383-391
[33]   Mode of action of an antiviral peptide from HIV-1 -: Inhibition at a post-lipid mixing stage [J].
Kliger, Y ;
Gallo, SA ;
Peisajovich, SG ;
Muñoz-Barroso, I ;
Avkin, S ;
Blumenthal, R ;
Shai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1391-1397
[34]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659
[35]   The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion [J].
Leikina, E ;
LeDuc, DL ;
Macosko, JC ;
Epand, R ;
Epand, R ;
Shin, YK ;
Chernomordik, LV .
BIOCHEMISTRY, 2001, 40 (28) :8378-8386
[36]   Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env [J].
Li, Kejun ;
Zhang, Shujing ;
Kronqvist, Malin ;
Wallin, Michael ;
Ekstrom, Maria ;
Derse, David ;
Garoff, Henrik .
JOURNAL OF VIROLOGY, 2008, 82 (14) :7135-7143
[37]   Role of a Putative gp41 Dimerization Domain in Human Immunodeficiency Virus Type 1 Membrane Fusion [J].
Liu, Jie ;
Deng, Yiqun ;
Li, Qunnu ;
Dey, Antu K. ;
Moore, John P. ;
Lu, Min .
JOURNAL OF VIROLOGY, 2010, 84 (01) :201-209
[38]   HIV gp41 C-terminal heptad repeat contains multifunctional domains - Relation to mechanisms of action of anti-HIV peptides [J].
Liu, Shuwen ;
Jing, Weiguo ;
Cheung, Byron ;
Lu, Hong ;
Sun, Jane ;
Yan, Xuxia ;
Niu, Jinkui ;
Farmar, James ;
Wu, Shuguang ;
Jiang, Shibo .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (13) :9612-9620
[39]   Different from the HIV fusion inhibitor C34, the anti-HIV drug fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120 [J].
Liu, SW ;
Lu, H ;
Niu, J ;
Xu, YJ ;
Wu, SG ;
Jiang, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11259-11273
[40]   A TRIMERIC STRUCTURAL DOMAIN OF THE HIV-1 TRANSMEMBRANE GLYCOPROTEIN [J].
LU, M ;
BLACKLOW, SC ;
KIM, PS .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (12) :1075-1082